What is Maraviroc, and what is it used for?
Maraviroc (also spelled maraviroc) is an antiretroviral medicine used to treat HIV-1 infection. It belongs to the drug class called CCR5 antagonists. Maraviroc blocks the CCR5 co-receptor on immune cells, which HIV-1 (when using CCR5 to enter cells) needs in order to infect the cell.
Because it targets a specific viral entry pathway, maraviroc is used when the patient’s HIV is compatible with CCR5-tropic infection (often determined by tropism testing).
How does maraviroc work in the body?
Maraviroc binds to the CCR5 receptor and prevents HIV-1 strains that use CCR5 from attaching and entering CD4+ T cells. HIV that uses a different entry route (for example, CXCR4-tropic virus) would not be expected to respond as well to a CCR5 blocker.
When is it prescribed instead of other HIV medicines?
Maraviroc is typically considered in treatment regimens when:
- the patient has HIV-1 that is CCR5-tropic (as confirmed by resistance/tropism testing), and
- clinicians want to include a CCR5 antagonist as part of combination antiretroviral therapy.
In practice, it is one component of a broader combination strategy rather than a stand-alone treatment.
What tropism testing is relevant for maraviroc?
Maraviroc’s effectiveness depends on whether the patient’s virus uses CCR5 to infect cells. Testing (tropism assays) is used to determine whether CCR5 is the relevant co-receptor before starting therapy and to guide regimen choice. If the virus is not CCR5-tropic, maraviroc is less likely to work.
What are common safety concerns people ask about?
Patients typically ask about side effects and risks because maraviroc works on a specific pathway and has important drug-interaction considerations. In particular, people often look for guidance on:
- adverse effects (including how soon they appear after starting or changing dose)
- drug-drug interactions that can raise or lower maraviroc levels
- monitoring needs and when to contact a clinician
If you share your context (for example: are you asking for general info, prescribing guidance, or side effects/interactions?), I can tailor the answer.
How do drug interactions affect maraviroc?
Like many antiretrovirals, maraviroc can interact with other medicines by changing how quickly it is metabolized or cleared. Clinicians consider:
- other HIV drugs used in the same regimen
- non-HIV medications (for example, certain antifungals, antibiotics, or seizure medicines)
- supplements that may alter drug levels
The practical takeaway is that maraviroc should be reviewed against the full medication list before starting or changing therapy.
What should someone discuss with a doctor before starting maraviroc?
Key questions to bring up include:
- whether your HIV is CCR5-tropic and what your tropism test showed
- your current antiretroviral regimen and how maraviroc will fit in
- your full medication list (including over-the-counter drugs and supplements)
- what monitoring is planned and what symptoms should prompt immediate contact with your care team
Sources
None provided in your message.